Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-17

Clinical Trial Update: Evaluation of the Optilume BPH Catheter System and the Rezum Water Vapor Therapy in Treating Benign Prostatic Hyperplasia [NA]

View source ↗

Summary

Clinical trial update indicating ongoing recruitment to evaluate the Optilume BPH Catheter System and Rezum Water Vapor Therapy for benign prostatic hyperplasia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Optilume BPH Catheter System
  • Rezum Water Vapor Therapy

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Benign Prostatic Hyperplasia (BPH), Lower Urinary Track Symptoms | NA | Status: RECRUITING